A new clinical trial explores whether targeted steam therapy can offer a less invasive, effective treatment for prostate ...

Prostate cancer waiting times could be radically cut by an 'extremely encouraging' 20 minute test, scientists have revealed.

Latham-based medical technology company AngioDynamics is ramping up marketing of its NanoKnife cancer treatment machine after receiving approval from the U.S. Food and Drug Administration for its use ...

After skin cancer, prostate cancer is the most common cancer in men in the US. A new treatment is giving men more options.

CURE provides access to the cancer news, latest oncology research & expert insights that serve as a guide to every stage of ...

Francis Medical has obtained $80 million in venture capital funding to support the development of its water vapor ablation ...

An estimated 610,000 people in the US died from cancer last year. That’s almost the same amount of people who perished in the country’s four-year civil war. At least two million more people were ...

Men with negative mpMRI results avoiding biopsy did not have increased risk for clinically significant prostate cancer.

Researchers at The Clatterbridge Cancer Centre NHS Foundation Trust are using AI to enhance the precision of radiotherapy for ...

A (Nasdaq: EDAP), the global leader in robotic energy-based therapies, today announced that the first patient has been treated in a phase I/II PULS Trial sponsored by the Centre Léon Bérard, Lyon, ...

Researchers conducted a post hoc, retrospective, cross-sectional analysis of 182 patients with recurrent prostate cancer ...

Francis Medical Inc., a Twin Cities med-tech manufacturer that's developing a way to treat prostrate and other cancers with water vapor, said Tuesday it raised $80 million in its latest equity funding ...